Clinical Trials Logo

Filter by:
NCT ID: NCT06044805 Completed - Malaria Clinical Trials

Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium Vivax

CQ+PQ
Start date: December 19, 2022
Phase: Phase 4
Study type: Interventional

The goal of this open label clinical trial will be to assess the therapeutic efficacy of chloroquine plus primaquine in the treatment of uncomplicated plasmodium vivax in Shecha Health Center, South Ethiopia. The main question it aims to answer:- the current therapeutic efficacy of chloroquine plus primaquine in the treatment of uncomplicated plasmodium vivax in Shecha Health Center, South Ethiopia based on clinical, parasitological and hematological parameter. Participants will be patients aged >6 months with diagnosis of plasmodium vivax mono-infection and who fulfills the inclusion criteria. This is a single arm open label invivo therapeutic efficacy study of chloroquine plus primaquine in the treatment of uncomplicated plasmodium vivax. The final result will be compared with World Health Organization recommendation on antimalarial drug therapeutic efficacy.

NCT ID: NCT06014671 Completed - Clinical trials for Breif Description: Patients' Quality of Life of

The Effect of Interpersonal Psychotherapy on Quality of Life Among People Living With HIVAIDS

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

Quality of life (QOL) is a significant importance for people living with HIV/AIDS by modifying the adverse psychosocial consequences that accompany the disease. In Ethiopia, interpersonal psychotherapy (IPT) has never been tried for people living with HIV/AIDS for quality of life. The objective of the study was to assess the effects of interpersonal psychotherapy on quality of life among PLWHA at Mettu Karl referral and Bedele hospital, southwest Ethiopia, 2022.

NCT ID: NCT05994326 Completed - Clinical trials for Colorectal Disorders

Perioperative Care and Short-term Outcomes of Colorectal Surgery in Addis Abeba

Start date: September 12, 2022
Phase:
Study type: Observational

Observational cohort study of adult patients undergoing colorectal surgery at Tikur Anbessa Specialized Hospital in Addis Abeba for 3 months.

NCT ID: NCT05972707 Completed - Clinical trials for Abdominal Wall Hernia

Magnitude, Types, and Associated Factors of External Abdominal Hernias Among Adult Patients Visiting the Surgical Outpatient Department at Hiwotfana Comprehensive Specialized Hospital and Jugol Regional Hospital, Eastern Ethiopia: A Cross-Sectional Study

Start date: October 20, 2022
Phase:
Study type: Observational

The study was aimed at determining the magnitude, types, and associated factors of external abdominal hernia among adult patients visiting the outpatient department at the Hiwot Fana Comprehensive Specialized Hospital (HFCSH) and Jugol regional hospital in eastern Ethiopia.

NCT ID: NCT05971888 Suspended - Dairy Consumption Clinical Trials

Better Dairy For All Evaluation in Ethiopia

Start date: August 1, 2024
Phase: N/A
Study type: Interventional

Global Alliance for Improved Nutrition (GAIN)'s "Better Dairy for All" program in Ethiopia seeks to improve children's and workers' consumption of healthy foods by improving access, increasing demand, and improving the enabling environment for dairy products by operating at multiple levels - individuals, households, markets, producers, and policies. RTI and local partners propose to conduct impact and process evaluations of GAIN's program tailored to the theory of change. The evaluation will include a mix of quantitative and qualitative methods and will be guided by the RE-AIM (reach, effectiveness, adoption, implementation, and maintenance) evaluation framework.

NCT ID: NCT05970458 Completed - Stoma Ileostomy Clinical Trials

Stoma Related Complications and Quality of Life Assessments Ethiopia and Sweden

Start date: October 1, 2022
Phase:
Study type: Observational

Cross-sectional comparative study of general and stoma-specific quality of life in patients with stoma in Addis Abeba, Ethiopia, and Stockholm, Sweden.

NCT ID: NCT05970055 Completed - Clinical trials for Postoperative Nausea and Vomiting

Prevalence and Associated Factors of Post-operative Nausea and Vomiting

Start date: February 1, 2022
Phase:
Study type: Observational

Postoperative nausea and vomiting (PONV) is a surgical complication defined as any nausea, and vomiting with in the first 24-48 hours after surgery in inpatients. Nausea is an unpleasant feeling or desire to vomit without expulsive muscular movement, while vomiting is a forceful expulsion or reflux of the gastric contents through the mouth. Postoperative nausea and vomiting is one of the most common complication associated anesthesia and surgery. It is considered the most common cause of morbidity, and it has significant effects on patient satisfaction. In spite of recent development of anesthesia and surgical techniques, the incidence of PONV remains high. This common anesthetic and surgical side effect has been reported to increase patient dissatisfaction and can be just as distressing to patients as postoperative pain is.

NCT ID: NCT05968872 Completed - Knowledge Clinical Trials

Assessing Knowledge & Attitude of Health Professionals Towards Anesthesia and the Anesthetist's Role.

Start date: May 1, 2022
Phase:
Study type: Observational [Patient Registry]

Misconceptions about anesthesia and anesthetists in the health professional community may limit anesthetists' participation in their roles. These misconceptions affect the morals of anesthetists since their activity will be limited only to operation theater and the community at large, who did not get the desired care. Improving health professionals' awareness of anesthesia will make it easier for anesthetists to practice their full role and to develop a sense of validation by having their importance acknowledged. Moreover, society will gate the care offered by the anesthetist in different places of medical care.

NCT ID: NCT05957978 Recruiting - Clinical trials for Primary Visceral Leishmaniasis

LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study

Start date: April 3, 2024
Phase: Phase 2
Study type: Interventional

This is a randomized, open-label, phase II, single-centre study, with one LXE408 regimen and one calibrator arm with the standard of care SSG combined with PM, to be conducted in male and female adult (≥18 years and <45 years) patients with confirmed primary visceral leishmaniasis in Ethiopia.

NCT ID: NCT05935904 Recruiting - Metabolic Syndrome Clinical Trials

Progression of Metabolic Syndrome Components During Pregnancy

MetS_Preg
Start date: June 27, 2023
Phase:
Study type: Observational [Patient Registry]

The goal of this cohort study is to investigate the underlying risk factors to develop metabolic syndrome (MetS) during pregnancy, and the associations of MetS and its indicators with birth outcomes in southwest Ethiopia. The study population consists of low-risk pregnant ladies in their first antenatal care visit (ANC), from Jimma Medical center. The main question[s] it aims to answer are: i) How do MetS components progress during pregnancy, and what are the underlying risk factors? ii) What is the association between MetS components during early- and late pregnancy and adverse pregnancy outcomes? iii) What is the knowledge, attitude and practices of women toward dietary habits, food taboos, and cultural beliefs during pregnancy? The study population consists of low-risk pregnant ladies in their first trimester (<15 weeks of pregnancy) in their first antenatal care visit (ANC) who will be followed up until one-month postpartum. Enrolled women will be assessed four times: at enrolment ≤15 weeks of pregnancy, mid-pregnancy (at 24 weeks), and late pregnancy (at 36 weeks), and within two weeks post-partum for: 1. Sociodemographic data 2. Dietary intake 3. Biochemical analyses 4. Maternal anthropometry: 5. Body composition in a subsample. 6. Knowledge, attitudes and practices of dietary practices during pregnancy 7. Pregnancy and birth outcomes: During the final visit, new born babies will be assessed for Apgar score, weight, length, and head circumference. The mother will be examined for general health and mode of delivery.